<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33167591</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>21</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>05</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">8311</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21218311</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal disease characterized by progressive muscle paralysis due to the degeneration of upper and lower motor neurons. Recent studies point out an involvement of the non-motor axis during disease progression. Despite smell impairment being considered a potential non-motor finding in ALS, the pathobiochemistry at the olfactory level remains unknown. Here, we applied an olfactory quantitative proteotyping approach to analyze the magnitude of the olfactory bulb (OB) proteostatic imbalance in ALS subjects (<i>n</i> = 12) with respect to controls (<i>n</i> = 8). Around 3% of the quantified OB proteome was differentially expressed, pinpointing aberrant protein expression involved in vesicle-mediated transport, macroautophagy, axon development and gliogenesis in ALS subjects. The overproduction of olfactory marker protein (<i>OMP</i>) points out an imbalance in the olfactory signal transduction in ALS. Accompanying the specific overexpression of glial fibrillary acidic protein (<i>GFAP</i>) and Bcl-xL in the olfactory tract (OT), a tangled disruption of signaling routes was evidenced across the OB-OT axis in ALS. In particular, the OB survival signaling dynamics clearly differ between ALS and frontotemporal lobar degeneration (FTLD), two faces of TDP-43 proteinopathy. To the best of our knowledge, this is the first report on high-throughput molecular characterization of the olfactory proteostasis in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lach&#xe9;n-Montes</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Neuroproteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P&#xfa;blica de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Proteored-ISCIII, Proteomics Platform, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P&#xfa;blica de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendizuri</LastName><ForeName>Naroa</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical Neuroproteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P&#xfa;blica de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ausin</LastName><ForeName>Karina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4914-9466</Identifier><AffiliationInfo><Affiliation>Proteored-ISCIII, Proteomics Platform, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P&#xfa;blica de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andr&#xe9;s-Benito</LastName><ForeName>Pol</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3000-0338</Identifier><AffiliationInfo><Affiliation>Bellvitge Biomedical Research Institute (IDIBELL), 08908 Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, 28031 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Experimental Therapeutics, University of Barcelona, 08007 Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Neurosciences, University of Barcelona, 08007 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrer</LastName><ForeName>Isidro</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-9888-8754</Identifier><AffiliationInfo><Affiliation>Bellvitge Biomedical Research Institute (IDIBELL), 08908 Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, 28031 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Experimental Therapeutics, University of Barcelona, 08007 Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Neurosciences, University of Barcelona, 08007 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Irigoyen</LastName><ForeName>Joaqu&#xed;n</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5072-4099</Identifier><AffiliationInfo><Affiliation>Clinical Neuroproteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P&#xfa;blica de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Proteored-ISCIII, Proteomics Platform, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P&#xfa;blica de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santamar&#xed;a</LastName><ForeName>Enrique</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8046-8102</Identifier><AffiliationInfo><Affiliation>Clinical Neuroproteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P&#xfa;blica de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Proteored-ISCIII, Proteomics Platform, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P&#xfa;blica de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PID2019-110356RB-I00</GrantID><Agency>Spanish Ministry of Science Innovation and Universities</Agency><Country/></Grant><Grant><GrantID>0011-1411-2020-000028</GrantID><Agency>Department of Economic and Business Development from Government of Navarra</Agency><Country/></Grant><Grant><GrantID>FISPI17/000809</GrantID><Agency>Ministry of Economy and Competiveness, Institute of Health Carlos III (ISCIII)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000628670">GFAP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005904">Glial Fibrillary Acidic Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="N">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005904" MajorTopicYN="N">Glial Fibrillary Acidic Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="N">Olfaction Disorders</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009830" MajorTopicYN="N">Olfactory Bulb</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">TDP-43 proteinopathy</Keyword><Keyword MajorTopicYN="N">olfactory bulb</Keyword><Keyword MajorTopicYN="N">olfactory tract</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword><Keyword MajorTopicYN="N">signaling</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>10</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33167591</ArticleId><ArticleId IdType="pmc">PMC7664257</ArticleId><ArticleId IdType="doi">10.3390/ijms21218311</ArticleId><ArticleId IdType="pii">ijms21218311</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R.H., Jr., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:1602. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">29045202</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Logroscino G., Traynor B., Collins J., Simeone J., Goldstein L., White L. Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature. Neuroepidemiology. 2013;41:118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2014;10:661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chio A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: What do we really know? Nat. Rev. Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerbury J.J., Farrawell N.E., McAlary L. Proteome Homeostasis Dysfunction: A Unifying Principle in ALS Pathogenesis. Trends Neurosci. 2020;43:274&#x2013;284. doi: 10.1016/j.tins.2020.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2020.03.002</ArticleId><ArticleId IdType="pubmed">32353332</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Van Damme P., Van Den Bosch L. Inside out: The role of nucleocytoplasmic transport in ALS and FTLD. Acta Neuropathol. 2016;132:159&#x2013;173. doi: 10.1007/s00401-016-1586-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1586-5</ArticleId><ArticleId IdType="pmc">PMC4947127</ArticleId><ArticleId IdType="pubmed">27271576</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.R., King O.D., Shorter J., Gitler A.D. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 2013;201:361&#x2013;372. doi: 10.1083/jcb.201302044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Polymenidou M., Cleveland D.W. Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O.M., Ghasemi M., Brown R.H., Jr. Emerging mechanisms of molecular pathology in ALS. J. Clin. Invest. 2015;125:1767&#x2013;1779. doi: 10.1172/JCI71601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI71601</ArticleId><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Calvo A., Chio A., Colville S., Ellis C.M., Hardiman O., Heverin M., Howard R.S., Huisman M.H.B., Keren N., et al. Analysis of amyotrophic lateral sclerosis as a multistep process: A population-based modelling study. Lancet. Neurol. 2014;13:1108&#x2013;1113. doi: 10.1016/S1474-4422(14)70219-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell J.R., Kiernan M.C., Vucic S., Hodges J.R. Motor neuron dysfunction in frontotemporal dementia. Brain. 2011;134:2582&#x2013;2594. doi: 10.1093/brain/awr195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr195</ArticleId><ArticleId IdType="pubmed">21840887</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramzon Y.A., Fratta P., Traynor B.J., Chia R. The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Neurosci. 2020;14:42. doi: 10.3389/fnins.2020.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00042</ArticleId><ArticleId IdType="pmc">PMC7012787</ArticleId><ArticleId IdType="pubmed">32116499</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F., Almeida S., Lopez-Gonzalez R. Dysregulated molecular pathways in amyotrophic lateral sclerosis&#x2013;frontotemporal dementia spectrum disorder. EMBO J. 2017;36:2931&#x2013;2950. doi: 10.15252/embj.201797568.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797568</ArticleId><ArticleId IdType="pmc">PMC5641681</ArticleId><ArticleId IdType="pubmed">28916614</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M.J., Abrahams S., Goldstein L.H., Woolley S., McLaughlin P., Snowden J., Mioshi E., Roberts-South A., Benatar M., Hortob&#xe1;gyi T., et al. Amyotrophic lateral sclerosis&#x2014;Frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph. Lateral Scler. Front. Degener. 2017;18:153&#x2013;174. doi: 10.1080/21678421.2016.1267768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Elian M. Olfactory impairment in motor neuron disease: A pilot study. J. Neurol. Neurosurg. Psychiatry. 1991;54:927&#x2013;928. doi: 10.1136/jnnp.54.10.927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.54.10.927</ArticleId><ArticleId IdType="pmc">PMC1014581</ArticleId><ArticleId IdType="pubmed">1744650</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkes C.H., Shephard B.C., Geddes J.F., Body G.D., Martin J.E. Olfactory disorder in motor neuron disease. Exp. Neurol. 1998;150:248&#x2013;253. doi: 10.1006/exnr.1997.6773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1997.6773</ArticleId><ArticleId IdType="pubmed">9527894</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty R.L. Olfactory dysfunction in neurodegenerative diseases: Is there a common pathological substrate? Lancet Neurol. 2017;16:478&#x2013;488. doi: 10.1016/S1474-4422(17)30123-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30123-0</ArticleId><ArticleId IdType="pubmed">28504111</ArticleId></ArticleIdList></Reference><Reference><Citation>Viguera C., Wang J., Mosmiller E., Cerezo A., Maragakis N.J. Olfactory dysfunction in amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 2018;5:976&#x2013;981. doi: 10.1002/acn3.594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.594</ArticleId><ArticleId IdType="pmc">PMC6093848</ArticleId><ArticleId IdType="pubmed">30128322</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Rossi F., Rinaldi F., Compostella S., Cosseddu M., Borroni B., Filosto M., Padovani A. Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. Neurodegener. Dis. 2016;16:411&#x2013;416. doi: 10.1159/000446802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000446802</ArticleId><ArticleId IdType="pubmed">27497596</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunther R., Schrempf W., Hahner A., Hummel T., Wolz M., Storch A., Hermann A. Impairment in Respiratory Function Contributes to Olfactory Impairment in Amyotrophic Lateral Sclerosis. Front. Neurol. 2018;9:79. doi: 10.3389/fneur.2018.00079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00079</ArticleId><ArticleId IdType="pmc">PMC5834512</ArticleId><ArticleId IdType="pubmed">29535673</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Escudero V., Rosales M., Munoz J.L., Scola E., Medina J., Khalique H., Garaulet G., Rodriguez A., Lim F. Patient-derived olfactory mucosa for study of the non-neuronal contribution to amyotrophic lateral sclerosis pathology. J. Cell Mol. Med. 2015;19:1284&#x2013;1295. doi: 10.1111/jcmm.12488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12488</ArticleId><ArticleId IdType="pmc">PMC4459844</ArticleId><ArticleId IdType="pubmed">25807871</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda T., Iijima M., Uchihara T., Ohashi T., Seilhean D., Duyckaerts C., Uchiyama S. TDP-43 Pathology Progression Along the Olfactory Pathway as a Possible Substrate for Olfactory Impairment in Amyotrophic Lateral Sclerosis. J. Neuropathol. Exp. Neurol. 2015;74:547&#x2013;556. doi: 10.1097/NEN.0000000000000198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000198</ArticleId><ArticleId IdType="pubmed">25933387</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson J., Sanelli T., Xiao S., Yang W., Horne P., Hammond R., Pioro E.P., Strong M.J. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS. Neurosci. Lett. 2007;420:128&#x2013;132. doi: 10.1016/j.neulet.2007.03.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2007.03.066</ArticleId><ArticleId IdType="pubmed">17543992</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringer C., Tune S., Bertoune M.A., Schwarzbach H., Tsujikawa K., Weihe E., Schutz B. Disruption of calcitonin gene-related peptide signaling accelerates muscle denervation and dampens cytotoxic neuroinflammation in SOD1 mutant mice. Cell Mol. Life Sci. 2017;74:339&#x2013;358. doi: 10.1007/s00018-016-2337-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2337-4</ArticleId><ArticleId IdType="pubmed">27554772</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringer C., Weihe E., Schutz B. SOD1G93A Mutant Mice Develop a Neuroinflammation-Independent Dendropathy in Excitatory Neuronal Subsets of the Olfactory Bulb and Retina. J. Neuropathol. Exp. Neurol. 2017;76:769&#x2013;778. doi: 10.1093/jnen/nlx057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlx057</ArticleId><ArticleId IdType="pubmed">28859334</ArticleId></ArticleIdList></Reference><Reference><Citation>Munger S.D., Leinders-Zufall T., Zufall F. Subsystem organization of the mammalian sense of smell. Annu Rev. Physiol. 2009;71:115&#x2013;140. doi: 10.1146/annurev.physiol.70.113006.100608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.physiol.70.113006.100608</ArticleId><ArticleId IdType="pubmed">18808328</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Del Tredici K., Toledo J.B., Robinson J.L., Irwin D.J., Grossman M., Suh E., Van Deerlin V.M., Wood E.M., Baek Y., et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima M., Tan R., Halliday G.M., Kril J.J. Spread of pathology in amyotrophic lateral sclerosis: Assessment of phosphorylated TDP-43 along axonal pathways. Acta Neuropathol. Commun. 2015;3:47. doi: 10.1186/s40478-015-0226-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0226-y</ArticleId><ArticleId IdType="pmc">PMC4517552</ArticleId><ArticleId IdType="pubmed">26216351</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedl T.J., San Gil R., Cheng F., Rayner S.L., Davidson J.M., De Luca A., Villalva M.D., Ecroyd H., Walker A.K., Lee A. Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD. Front. Neurosci. 2019;13:548. doi: 10.3389/fnins.2019.00548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00548</ArticleId><ArticleId IdType="pmc">PMC6579929</ArticleId><ArticleId IdType="pubmed">31244593</ArticleId></ArticleIdList></Reference><Reference><Citation>Iridoy M.O., Zubiri I., Zelaya M.V., Martinez L., Ausin K., Lachen-Montes M., Santamaria E., Fernandez-Irigoyen J., Jerico I. Neuroanatomical Quantitative Proteomics Reveals Common Pathogenic Biological Routes between Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Int. J. Mol. Sci. 2018;20:4. doi: 10.3390/ijms20010004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20010004</ArticleId><ArticleId IdType="pmc">PMC6337647</ArticleId><ArticleId IdType="pubmed">30577465</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P., Sidle K.C., Hardy J. Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS) Neuropathol. Appl. Neurobiol. 2015;41:578&#x2013;597. doi: 10.1111/nan.12206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12206</ArticleId><ArticleId IdType="pubmed">25487060</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Cleveland D.W. The seeds of neurodegeneration: Prion-like spreading in ALS. Cell. 2011;147:498&#x2013;508. doi: 10.1016/j.cell.2011.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.10.011</ArticleId><ArticleId IdType="pmc">PMC3220614</ArticleId><ArticleId IdType="pubmed">22036560</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey N.L., Wesson D.W., Brundin P. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol. Dis. 2018;109:226&#x2013;248. doi: 10.1016/j.nbd.2016.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.12.013</ArticleId><ArticleId IdType="pmc">PMC5972535</ArticleId><ArticleId IdType="pubmed">28011307</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Irigoyen J., Santamaria E. Olfactory proteotyping: Towards the enlightenment of the neurodegeneration. Neural Regen Res. 2019;14:979&#x2013;981. doi: 10.4103/1673-5374.249220.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.249220</ArticleId><ArticleId IdType="pmc">PMC6404500</ArticleId><ArticleId IdType="pubmed">30762007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachen-Montes M., Gonzalez-Morales A., Iloro I., Elortza F., Ferrer I., Gveric D., Fernandez-Irigoyen J., Santamaria E. Unveiling the olfactory proteostatic disarrangement in Parkinson&#x2019;s disease by proteome-wide profiling. Neurobiol. Aging. 2019;73:123&#x2013;134. doi: 10.1016/j.neurobiolaging.2018.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.09.018</ArticleId><ArticleId IdType="pubmed">30342273</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachen-Montes M., Gonzalez-Morales A., Zelaya M.V., Perez-Valderrama E., Ausin K., Ferrer I., Fernandez-Irigoyen J., Santamaria E. Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer&#x2019;s disease progression. Sci. Rep. 2017;7:9115. doi: 10.1038/s41598-017-09481-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09481-x</ArticleId><ArticleId IdType="pmc">PMC5567385</ArticleId><ArticleId IdType="pubmed">28831118</ArticleId></ArticleIdList></Reference><Reference><Citation>Acquadro E., Caron I., Tortarolo M., Bucci E.M., Bendotti C., Corpillo D. Human SOD1-G93A specific distribution evidenced in murine brain of a transgenic model for amyotrophic lateral sclerosis by MALDI imaging mass spectrometry. J. Proteome Res. 2014;13:1800&#x2013;1809. doi: 10.1021/pr400942n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr400942n</ArticleId><ArticleId IdType="pubmed">24579824</ArticleId></ArticleIdList></Reference><Reference><Citation>Togawa J., Ohi T., Yuan J.H., Takashima H., Furuya H., Takechi S., Fujitake J., Hayashi S., Ishiura H., Naruse H., et al. Atypical Familial Amyotrophic Lateral Sclerosis with Slowly Progressing Lower Extremities-predominant Late-onset Muscular Weakness and Atrophy. Intern. Med. 2019;58:1851&#x2013;1858. doi: 10.2169/internalmedicine.2222-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.2222-18</ArticleId><ArticleId IdType="pmc">PMC6663526</ArticleId><ArticleId IdType="pubmed">31257275</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberstadt M., Classen J., Arendt T., Holzer M. TDP-43 and Cytoskeletal Proteins in ALS. Mol. Neurobiol. 2018;55:3143&#x2013;3151. doi: 10.1007/s12035-017-0543-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0543-1</ArticleId><ArticleId IdType="pubmed">28466273</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckl P., Weydt P., Thal D.R., Weishaupt J.H., Ludolph A.C., Otto M. Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis. Acta Neuropathol. 2020;139:119&#x2013;134. doi: 10.1007/s00401-019-02093-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02093-x</ArticleId><ArticleId IdType="pubmed">31701227</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekblom J., Aquilonius S.M., Jossan S.S. Differential increases in catecholamine metabolizing enzymes in amyotrophic lateral sclerosis. Exp. Neurol. 1993;123:289&#x2013;294. doi: 10.1006/exnr.1993.1161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1993.1161</ArticleId><ArticleId IdType="pubmed">8405291</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Houseweart M.K., Brown R.H., Jr., Cleveland D.W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2000;97:13901&#x2013;13906. doi: 10.1073/pnas.240305897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.240305897</ArticleId><ArticleId IdType="pmc">PMC17673</ArticleId><ArticleId IdType="pubmed">11095709</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou S.M., Taniguchi A., Wang H.S., Festoff B.W. Serpin=serine protease-like complexes within neurofilament conglomerates of motoneurons in amyotrophic lateral sclerosis. J. Neurol. Sci. 1998;160(Suppl. 1):S73&#x2013;S79. doi: 10.1016/S0022-510X(98)00202-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(98)00202-0</ArticleId><ArticleId IdType="pubmed">9851654</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques R.F., Engler J.B., Kuchler K., Jones R.A., Lingner T., Salinas G., Gillingwater T.H., Friese M.A., Duncan K.E. Motor neuron translatome reveals deregulation of SYNGR4 and PLEKHB1 in mutant TDP-43 amyotrophic lateral sclerosis models. Hum. Mol. Genet. 2020 doi: 10.1093/hmg/ddaa140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa140</ArticleId><ArticleId IdType="pmc">PMC7530531</ArticleId><ArticleId IdType="pubmed">32686835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahia El Idrissi N., Bosch S., Ramaglia V., Aronica E., Baas F., Troost D. Complement activation at the motor end-plates in amyotrophic lateral sclerosis. J. Neuroinflamm. 2016;13:72. doi: 10.1186/s12974-016-0538-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0538-2</ArticleId><ArticleId IdType="pmc">PMC4823861</ArticleId><ArticleId IdType="pubmed">27056040</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisert J., Yau K.W., Margolis F.L. Olfactory marker protein modulates the cAMP kinetics of the odour-induced response in cilia of mouse olfactory receptor neurons. J. Physiol. 2007;585:731&#x2013;740. doi: 10.1113/jphysiol.2007.142471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2007.142471</ArticleId><ArticleId IdType="pmc">PMC2375515</ArticleId><ArticleId IdType="pubmed">17932148</ArticleId></ArticleIdList></Reference><Reference><Citation>Buiakova O.I., Baker H., Scott J.W., Farbman A., Kream R., Grillo M., Franzen L., Richman M., Davis L.M., Abbondanzo S., et al. Olfactory marker protein (OMP) gene deletion causes altered physiological activity of olfactory sensory neurons. Proc. Natl. Acad. Sci. USA. 1996;93:9858&#x2013;9863. doi: 10.1073/pnas.93.18.9858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.18.9858</ArticleId><ArticleId IdType="pmc">PMC38519</ArticleId><ArticleId IdType="pubmed">8790421</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakashima N., Nakashima K., Taura A., Takaku-Nakashima A., Ohmori H., Takano M. Olfactory marker protein directly buffers cAMP to avoid depolarization-induced silencing of olfactory receptor neurons. Nat. Commun. 2020;11:2188. doi: 10.1038/s41467-020-15917-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15917-2</ArticleId><ArticleId IdType="pmc">PMC7198493</ArticleId><ArticleId IdType="pubmed">32366818</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A.C., He J., Ma M. Olfactory marker protein is critical for functional maturation of olfactory sensory neurons and development of mother preference. J. Neurosci. 2011;31:2974&#x2013;2982. doi: 10.1523/JNEUROSCI.5067-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5067-10.2011</ArticleId><ArticleId IdType="pmc">PMC3084592</ArticleId><ArticleId IdType="pubmed">21414919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kass M.D., Moberly A.H., Rosenthal M.C., Guang S.A., McGann J.P. Odor-specific, olfactory marker protein-mediated sparsening of primary olfactory input to the brain after odor exposure. J. Neurosci. 2013;33:6594&#x2013;6602. doi: 10.1523/JNEUROSCI.1442-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1442-12.2013</ArticleId><ArticleId IdType="pmc">PMC3865540</ArticleId><ArticleId IdType="pubmed">23575856</ArticleId></ArticleIdList></Reference><Reference><Citation>Albeanu D.F., Provost A.C., Agarwal P., Soucy E.R., Zak J.D., Murthy V.N. Olfactory marker protein (OMP) regulates formation and refinement of the olfactory glomerular map. Nat. Commun. 2018;9:5073. doi: 10.1038/s41467-018-07544-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07544-9</ArticleId><ArticleId IdType="pmc">PMC6265328</ArticleId><ArticleId IdType="pubmed">30498219</ArticleId></ArticleIdList></Reference><Reference><Citation>Tepe B., Hill M.C., Pekarek B.T., Hunt P.J., Martin T.J., Martin J.F., Arenkiel B.R. Single-Cell RNA-Seq of Mouse Olfactory Bulb Reveals Cellular Heterogeneity and Activity-Dependent Molecular Census of Adult-Born Neurons. Cell Rep. 2018;25:2689&#x2013;2703.e2683. doi: 10.1016/j.celrep.2018.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.11.034</ArticleId><ArticleId IdType="pmc">PMC6342206</ArticleId><ArticleId IdType="pubmed">30517858</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen K., Sloan S.A., Bennett M.L., Scholze A.R., O&#x2019;Keeffe S., Phatnani H.P., Guarnieri P., Caneda C., Ruderisch N., et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 2014;34:11929&#x2013;11947. doi: 10.1523/JNEUROSCI.1860-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1860-14.2014</ArticleId><ArticleId IdType="pmc">PMC4152602</ArticleId><ArticleId IdType="pubmed">25186741</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciryam P., Lambert-Smith I.A., Bean D.M., Freer R., Cid F., Tartaglia G.G., Saunders D.N., Wilson M.R., Oliver S.G., Morimoto R.I., et al. Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS. Proc. Natl. Acad. Sci. USA. 2017;114:E3935&#x2013;E3943. doi: 10.1073/pnas.1613854114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1613854114</ArticleId><ArticleId IdType="pmc">PMC5441770</ArticleId><ArticleId IdType="pubmed">28396410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ethell D.W. Disruption of cerebrospinal fluid flow through the olfactory system may contribute to Alzheimer&#x2019;s disease pathogenesis. J. Alzheimers Dis. 2014;41:1021&#x2013;1030. doi: 10.3233/JAD-130659.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-130659</ArticleId><ArticleId IdType="pubmed">24769627</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachen-Montes M., Fernandez-Irigoyen J., Santamaria E. Deconstructing the molecular architecture of olfactory areas using proteomics. Proteom. Clin. Appl. 2016 doi: 10.1002/prca.201500147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.201500147</ArticleId><ArticleId IdType="pubmed">27226001</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachen-Montes M., Gonzalez-Morales A., Fernandez-Irigoyen J., Santamaria E. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies. Methods Mol. Biol. 2019;2044:273&#x2013;289. doi: 10.1007/978-1-4939-9706-0_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9706-0_17</ArticleId><ArticleId IdType="pubmed">31432419</ArticleId></ArticleIdList></Reference><Reference><Citation>Macron C., Lavigne R., Nunez Galindo A., Affolter M., Pineau C., Dayon L. Exploration of human cerebrospinal fluid: A large proteome dataset revealed by trapped ion mobility time-of-flight mass spectrometry. Data Brief. 2020;31:105704. doi: 10.1016/j.dib.2020.105704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dib.2020.105704</ArticleId><ArticleId IdType="pmc">PMC7251648</ArticleId><ArticleId IdType="pubmed">32478154</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Kannagi M., Ferrante R.J., Kowall N.W., Ryu H. Activation of Ets-2 by oxidative stress induces Bcl-xL expression and accounts for glial survival in amyotrophic lateral sclerosis. FASEB J. 2009;23:1739&#x2013;1749. doi: 10.1096/fj.08-121046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.08-121046</ArticleId><ArticleId IdType="pmc">PMC2698657</ArticleId><ArticleId IdType="pubmed">19179380</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomo V., Nozal V., Rojas-Prats E., Gil C., Martinez A. Protein kinase inhibitors for amyotrophic lateral sclerosis therapy. Br. J. Pharmacol. 2020 doi: 10.1111/bph.15221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15221</ArticleId><ArticleId IdType="pubmed">32737989</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachen-Montes M., Gonzalez-Morales A., Schvartz D., Zelaya M.V., Ausin K., Fernandez-Irigoyen J., Sanchez J.C., Santamaria E. The olfactory bulb proteotype differs across frontotemporal dementia spectrum. J. Proteom. 2019;201:37&#x2013;47. doi: 10.1016/j.jprot.2019.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2019.04.011</ArticleId><ArticleId IdType="pubmed">30999060</ArticleId></ArticleIdList></Reference><Reference><Citation>Baczyk M., Alami N.O., Delestree N., Martinot C., Tang L., Commisso B., Bayer D., Doisne N., Frankel W., Manuel M., et al. Synaptic restoration by cAMP/PKA drives activity-dependent neuroprotection to motoneurons in ALS. J. Exp. Med. 2020;217 doi: 10.1084/jem.20191734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20191734</ArticleId><ArticleId IdType="pmc">PMC7398175</ArticleId><ArticleId IdType="pubmed">32484501</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger C., Lanius R.A., Pelech S.L., Shaw C.A. Amyotrophic lateral sclerosis: The involvement of intracellular Ca2+ and protein kinase C. Trends Pharmacol. Sci. 1996;17:114&#x2013;120. doi: 10.1016/0165-6147(96)10004-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-6147(96)10004-3</ArticleId><ArticleId IdType="pubmed">8936348</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanuza M.A., Santafe M.M., Garcia N., Besalduch N., Tomas M., Obis T., Priego M., Nelson P.G., Tomas J. Protein kinase C isoforms at the neuromuscular junction: Localization and specific roles in neurotransmission and development. J. Anat. 2014;224:61&#x2013;73. doi: 10.1111/joa.12106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joa.12106</ArticleId><ArticleId IdType="pmc">PMC3867888</ArticleId><ArticleId IdType="pubmed">24102585</ArticleId></ArticleIdList></Reference><Reference><Citation>Camerino G.M., Fonzino A., Conte E., De Bellis M., Mele A., Liantonio A., Tricarico D., Tarantino N., Dobrowolny G., Musaro A., et al. Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options. Sci. Rep. 2019;9:3185. doi: 10.1038/s41598-019-39676-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39676-3</ArticleId><ArticleId IdType="pmc">PMC6395744</ArticleId><ArticleId IdType="pubmed">30816241</ArticleId></ArticleIdList></Reference><Reference><Citation>Migheli A., Piva R., Atzori C., Troost D., Schiffer D. c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1997;56:1314&#x2013;1322. doi: 10.1097/00005072-199712000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199712000-00006</ArticleId><ArticleId IdType="pubmed">9413280</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala V., Granado-Serrano A.B., Cacabelos D., Naudi A., Ilieva E.V., Boada J., Caraballo-Miralles V., Llado J., Ferrer I., Pamplona R., et al. Cell stress induces TDP-43 pathological changes associated with ERK1/2 dysfunction: Implications in ALS. Acta Neuropathol. 2011;122:259&#x2013;270. doi: 10.1007/s00401-011-0850-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0850-y</ArticleId><ArticleId IdType="pubmed">21706176</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M.J., Kesavapany S., Pant H.C. The pathobiology of amyotrophic lateral sclerosis: A proteinopathy? J. Neuropathol. Exp. Neurol. 2005;64:649&#x2013;664. doi: 10.1097/01.jnen.0000173889.71434.ea.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000173889.71434.ea</ArticleId><ArticleId IdType="pubmed">16106213</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerley S., Grierson A.J., Banner S., Perkinton M.S., Brownlees J., Byers H.L., Ward M., Thornhill P., Hussain K., Waby J.S., et al. p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol. Cell Neurosci. 2004;26:354&#x2013;364. doi: 10.1016/j.mcn.2004.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2004.02.009</ArticleId><ArticleId IdType="pubmed">15207859</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J.H., Zhang H., Wagey R., Krieger C., Pelech S.L. Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord. J. Neurochem. 2003;85:432&#x2013;442. doi: 10.1046/j.1471-4159.2003.01670.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01670.x</ArticleId><ArticleId IdType="pubmed">12675919</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M.J., Horob&#xe1;gyi T., Okamoto K., Kato S. Amyotrophic lateral sclerosis, primary lateral sclerosis and spinal muscular atrophy. In: Dickson D.W., Weller R.O., editors. Molecular Pathology of Dementia and Movement Disorders. 2nd ed. Blackwell Publish Ltd.; Oxford, UK: 2011. pp. 418&#x2013;433. 2011 International Society of Neuropathology.</Citation></Reference><Reference><Citation>Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008;26:1367&#x2013;1372. doi: 10.1038/nbt.1511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1511</ArticleId><ArticleId IdType="pubmed">19029910</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyanova S., Temu T., Sinitcyn P., Carlson A., Hein M.Y., Geiger T., Mann M., Cox J. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods. 2016;13:731&#x2013;740. doi: 10.1038/nmeth.3901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3901</ArticleId><ArticleId IdType="pubmed">27348712</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizcaino J.A., Deutsch E.W., Wang R., Csordas A., Reisinger F., Rios D., Dianes J.A., Sun Z., Farrah T., Bandeira N., et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 2014;32:223&#x2013;226. doi: 10.1038/nbt.2839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2839</ArticleId><ArticleId IdType="pmc">PMC3986813</ArticleId><ArticleId IdType="pubmed">24727771</ArticleId></ArticleIdList></Reference><Reference><Citation>Oughtred R., Stark C., Breitkreutz B.J., Rust J., Boucher L., Chang C., Kolas N., O&#x2019;Donnell L., Leung G., McAdam R., et al. The BioGRID interaction database: 2019 update. Nucleic Acids Res. 2019;47:D529&#x2013;D541. doi: 10.1093/nar/gky1079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1079</ArticleId><ArticleId IdType="pmc">PMC6324058</ArticleId><ArticleId IdType="pubmed">30476227</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhou B., Pache L., Chang M., Khodabakhshi A.H., Tanaseichuk O., Benner C., Chanda S.K. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 2019;10:1523. doi: 10.1038/s41467-019-09234-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09234-6</ArticleId><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>